Helmut Lambertz

<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer

Christoph Heining, Peter Horak, Sebastian Uhrig et al. · Cancer Discovery · 2018 · 239 citations · Full text

Medicine, Genetics, Neoplasia +13

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

Ludwig Fischer von Weikersthal, Andreas Schalhorn, Martina Stauch et al. · European Journal of Cancer · 2010 · 59 citations

Medicine, Oncology, Pharmacology +13

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Jean‐François Emile, Catherine Julié, Karine Le Malicot et al. · European Journal of Cancer · 2017 · 46 citations · Full text

Medicine, Immunology, Oncology +17

Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report

Katja Sonntag, Hisayoshi Hashimoto, Matthias Eyrich et al. · Journal of Translational Medicine · 2018 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials

Steffen Ormanns, Michael Haas, Sibylle Baechmann et al. · British Journal of Cancer · 2016 · 22 citations · Full text

Medicine, Oncology, Pathology +17